Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

MNTL vs. IXJ: which is better?

Bottom line

MNTL vs IXJ: the short answer

MNTL (Tema Neuroscience and Mental Health ETF) and IXJ (iShares Global Healthcare ETF) are both etfs.

Updated Nov 19, 2026

MNTL vs IXJ side by side

MNTLIXJ
TypeETFETF
Fund familyInnovatoriShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.38%
Annual cost per $10k—$38
10-yr cost on $10k (prospectus)—$480
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+14.9%
5-yr return (annualized)—+6.4%
10-yr return (annualized)—+8.2%
Best quarter—+13.6%
Worst quarter—−11.8%
Net assets (fund)—$3.8B
Number of holdings—124
Portfolio turnover—2%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

MNTL and IXJ share none of their top holdings.

MNTL top 10

    IXJ top 10

    1. Eli Lilly And Company — 10.93%
    2. Johnson & Johnson — 7.04%
    3. Abbvie Inc. — 5.12%
    4. Unitedhealth Group Incorporated — 4.40%
    5. Merck & Co., Inc. — 4.12%
    6. Astrazeneca Plc — 3.76%
    7. Roche Holding AG — 3.75%
    8. Novartis AG — 3.71%
    9. Amgen Inc. — 2.54%
    10. Thermo Fisher Scientific Incorporated — 2.42%

    FAQ

    What is the difference between MNTL and IXJ?
    MNTL (Tema Neuroscience and Mental Health ETF) and IXJ (iShares Global Healthcare ETF) are both etfs.
    Should I own both MNTL and IXJ?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.